Similar articles

• Lung cancer screening gets risk-specific.

  Peres J. Peres J. J Natl Cancer Inst. 2013 Jan 2;105(1):1-2. doi: 10.1093/jnci/djs631. Epub 2012 Dec 20. J Natl Cancer Inst. 2013. PMID: 23257155 No abstract available.
• [Systematic PSA screening has been tried in Region Skåne. Balanced information gives chance for equal treatment according to a pilot project].

  Bratt O, Lundgren R, Ahlgren G. Bratt O, et al. Lakartidningen. 2012 Sep 12-18;109(37):1610-2. Lakartidningen. 2012. PMID: 23077769 Swedish. No abstract available.
• New PSA guidelines discourage overscreening.

  Peres J. Peres J. J Natl Cancer Inst. 2012 Jan 4;104(1):8-9. doi: 10.1093/jnci/djr539. Epub 2011 Dec 14. J Natl Cancer Inst. 2012. PMID: 22173585 No abstract available.
• PSA-based screening for prostate cancer. Too many adverse effects.

  [No authors listed] [No authors listed] Prescrire Int. 2012 Sep;21(130):215-7. Prescrire Int. 2012. PMID: 23016259 Review.
• [The PSA test does not hold for screening. Good--but not good enough].

  Holmström B, Johansson M, Bratt O, Stattin P. Holmström B, et al. Lakartidningen. 2010 Feb 17-23;107(7):436, 438-9. Lakartidningen. 2010. PMID: 20384076 Review. Swedish. No abstract available.